Trial Profile
Efficacy of an Intravitreal Dexamethasone Implant on Macular Function in Retinal Vein Occlusion Following Treatment With Intravitreal Anti-VEGF Injections.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Retinal vein occlusion
- Focus Therapeutic Use
- 26 Apr 2017 Status changed from active, no longer recruiting to completed.
- 13 Nov 2014 New trial record